AU

Anton Uvarov

BlinkLab Limited | Executive Director
Dr Uvarov has experience as an equity analyst in the healthcare industry with a focus on the biotechnology sector, both domestically and internationally. Prior to moving to Australia, he was with Citigroup Global Markets where he spent two years as a member of a New York based biotechnology team that has been continuously ranked top 4 for Biotechnology in the All-America Institutional Investor survey. Dr Uvarov's scientific expertise and company knowledge spreads across a variety of therapeutic areas and spectrum of market capitalizations with his particular interest in early-stage biotechnology companies.

Companies and Roles

Company
Title
Tenure
Since
BB1
BlinkLab Limited
  • Executive Director
1mthApr 2024
NSB
NeuroScientific Biopharmaceuticals Ltd
  • Non-Executive Director
1yrs, 6mthNov 2022

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
BB1
BlinkLab Limited
02/04/24N/A8,500,0002,000,000N/A
NSB
NeuroScientific Biopharmaceuticals Ltd
25/08/232,350,000N/A1,700,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
NSB
NeuroScientific Biopharmaceuticals Ltd
22/05/23
Buy
49,405$0.105$5,188On-market trade
NSB
NeuroScientific Biopharmaceuticals Ltd
18/05/23
Buy
275,595$0.084$23,188On-market trade
NSB
NeuroScientific Biopharmaceuticals Ltd
07/12/21
Issued
900,000$0.320$288,000Director remuneration
NSB
NeuroScientific Biopharmaceuticals Ltd
25/02/21
Exercise
400,000$0.200$80,000Exercise of options
NSB
NeuroScientific Biopharmaceuticals Ltd
25/02/21
Buy
400,000$0.200$80,000Exercise of options